Centralized Pharmacy System for Sensitive Drug Abuse Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for a drug distribution system that effectively addresses the abuse and diversion of sensitive drugs by implementing additional controls and education measures beyond traditional methods, as existing systems fail to prevent illegal distribution and misuse.
Innovation Solution
A centralized pharmacy and database system tracks prescriptions, verifies physician eligibility, and educates both physicians and patients, with multiple controls in place to prevent abuse, including monitoring prescription patterns, using courier services for delivery confirmation, and limiting refills, while providing education on the risks and benefits of sensitive drugs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a centralized tracking system is implemented to monitor all prescriptions and patients, then the ability to detect and prevent abuse is improved, but the system complexity increases
Solution Approach 1:
The system segments the monitoring function by creating separate databases for physicians and patients, with specific tracking modules for prescription patterns, refill histories, and delivery confirmations. This segmentation allows the complex anti-abuse system to be managed through modular, organized components rather than a monolithic structure.
Solution Approach 2:
The patent introduces a central pharmacy as an intermediary between physicians and patients, which serves as the hub for all prescription monitoring, verification, and distribution. This intermediary role consolidates control while maintaining system manageability through a single coordinated entity that handles all sensitive drug transactions.
2Reliability
If multiple verification steps are required for physician eligibility and patient receipt confirmation, then the safety against diversion is improved, but the time required for distribution increases
Solution Approach 1:
The system performs preliminary verification of physician eligibility and patient authorization before the actual drug distribution occurs. By completing background checks, license validations, and education confirmations in advance, the system ensures safety requirements are met without delaying the actual medication delivery when needed.
Solution Approach 2:
The patent implements feedback mechanisms where patients are contacted to confirm receipt of educational materials and drug delivery, and where prescription patterns are continuously monitored. This feedback loop allows for real-time verification while maintaining efficient workflows through automated notifications and tracking systems.
3Reliability
If education and monitoring controls are imposed on all distribution, then the prevention of abuse is improved, but the ease of operation for legitimate patients is reduced
Solution Approach 1:
The system enables patients to self-manage their prescriptions through automated tracking, where they can view their medication histories, receive refill notifications, and confirm deliveries through the central pharmacy's online system. This self-service approach reduces the need for manual intervention while maintaining security controls.
Solution Approach 2:
The patent applies different control parameters based on the sensitivity level of the drug and the patient's history. By adjusting monitoring intensity, verification requirements, and access levels according to individual circumstances, the system maintains ease of operation for legitimate patients while strengthening controls where abuse risk is detected.
Data Source
AI summary
A drug distribution system and method utilizes a central pharmacy and database to track all prescriptions for a sensitive drug. Information is kept in the database regarding all physicians allowed to prescribe the sensitive drug, and all patients receiving the drug. Abuses are identified by monitoring data in the database for prescription patterns by physicians and prescriptions obtained by patients. Further verification is made that the physician is eligible to prescribe the drug by consulting a separate database, and optionally whether any actions are taken against the physician. Multiple controls beyond those for normal drugs are imposed on the distribution depending on the sensitivity of the drug.